Literature DB >> 16275192

Use of autonomic maneuvers to probe phenotype/genotype discordance in congenital long QT syndrome.

Elizabeth S Kaufman1, Eiran Z Gorodeski, Mary M Dettmer, Maria Dikshteyn.   

Abstract

Patients with congenital long QT syndrome due to potassium channel mutations (LQT1 and LQT2) may elude diagnosis due to normal electrocardiographic findings at rest, yet remain at risk of sudden death during bradycardia or sympathetic stimulation. To test the hypothesis that autonomic maneuvers can unmask long QT syndrome in genetically abnormal subjects with a normal phenotype (QTc < or =450 ms), we exposed 13 controls (33 +/- 9 years; 5 men), 5 patients with LQT1 (32 +/- 12 years; 3 men), and 5 patients with LQT2 (30 +/- 11 years; 5 men) to phenylephrine bolus, exercise, and epinephrine infusion. The QT interval was measured at baseline and after each intervention. A substantial overlap was found in QTc among the groups at baseline and after phenylephrine. In contrast, QTc was significantly and consistently longer in subjects with LQT1 compared with controls during and after exercise (492 +/- 40 vs 407 +/- 14 ms, p <0.0001, at peak exercise; 498 +/- 30 vs 399 +/- 20 ms, p <0.0001, at 1 minute into recovery) or epinephrine (623 +/- 51 vs 499 +/- 51 ms, p <0.001, at peak epinephrine; 604 +/- 36 vs 507 +/- 54 ms, p <0.01, at 1 minute into recovery) but not in subjects with LQT2. In conclusion, sympathetic stimulation can reveal the LQT1 phenotype even in subjects with normal baseline electrocardiographic findings.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16275192     DOI: 10.1016/j.amjcard.2005.07.046

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  7 in total

1.  β-blockers protect against dispersion of repolarization during exercise in congenital long-QT syndrome type 1.

Authors:  Lee W Gemma; Gregory M Ward; Mary M Dettmer; Jennifer L Ball; Peter J Leo; Danielle N Doria; Elizabeth S Kaufman
Journal:  J Cardiovasc Electrophysiol       Date:  2011-06-02

2.  Electrocardiographic Impact of Myocardial Diffuse Fibrosis and Scar: MESA (Multi-Ethnic Study of Atherosclerosis).

Authors:  Yuko Y Inoue; Bharath Ambale-Venkatesh; Nathan Mewton; Gustavo J Volpe; Yoshiaki Ohyama; Ravi K Sharma; Colin O Wu; Chia-Ying Liu; David A Bluemke; Elsayed Z Soliman; João A C Lima; Hiroshi Ashikaga
Journal:  Radiology       Date:  2016-10-13       Impact factor: 11.105

3.  The QT interval is associated with incident cardiovascular events: the MESA study.

Authors:  Roy Beinart; Yiyi Zhang; João A C Lima; David A Bluemke; Elsayed Z Soliman; Susan R Heckbert; Wendy S Post; Eliseo Guallar; Saman Nazarian
Journal:  J Am Coll Cardiol       Date:  2014-11-10       Impact factor: 24.094

4.  J-curve relationship between corrected QT interval and mortality in acute heart failure patients.

Authors:  Chan Soon Park; Hyun-Jai Cho; Eue-Keun Choi; Sang Eun Lee; Min-Seok Kim; Jae-Joong Kim; Jin-Oh Choi; Eun-Seok Jeon; Kyung-Kuk Hwang; Shung Chull Chae; Sang Hong Baek; Seok-Min Kang; Byungsu Yoo; Dong-Ju Choi; Youngkeun Ahn; Kye-Hoon Kim; Myeong-Chan Cho; Byung-Hee Oh; Hae-Young Lee
Journal:  Korean J Intern Med       Date:  2020-05-08       Impact factor: 2.884

5.  Association Between Dynamic Change of QT Interval and Long-Term Cardiovascular Outcomes: A Prospective Cohort Study.

Authors:  Min Ye; Jing-Wei Zhang; Jia Liu; Ming Zhang; Feng-Juan Yao; Yun-Jiu Cheng
Journal:  Front Cardiovasc Med       Date:  2021-11-30

6.  The role of the epinephrine test in the diagnosis and management of children suspected of having congenital long QT syndrome.

Authors:  Sally-Ann B Clur; Priya Chockalingam; Luc H Filippini; Ari P Widyanti; Marc Van Cruijsen; Nico A Blom; Mariel Alders; Nynke Hofman; Arthur A M Wilde
Journal:  Pediatr Cardiol       Date:  2009-12-03       Impact factor: 1.655

Review 7.  Long QT Syndrome: An Emerging Role for Inflammation and Immunity.

Authors:  Pietro Enea Lazzerini; Pier Leopoldo Capecchi; Franco Laghi-Pasini
Journal:  Front Cardiovasc Med       Date:  2015-05-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.